Advertisement
Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated (CORT) Stock Overview

Explore Corcept Therapeutics Incorporated’s financial performance, market position, analyst ratings, and future outlook.

CORT●NASDAQ
HealthcareBiotechnology
$74.89
$2.24(3.08%)
U.S. Market opens in 16h 8m
Advertisement

Corcept Therapeutics Incorporated (CORT)

Meyka AI Score

Z

Key Financials

Market Cap8B
P/E Ratio157.80
EPS (TTM)$0.35
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$55.48
3 Months$48.00
1 Year Target$85.68

CORT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Corcept Therapeutics Incorporated (CORT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 86.90, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $85.68.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 157.80 and a market capitalization of 8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.08%
5-Day Change
9.22%
1-Month Change
45.14%
3-Month Change
109.83%
6-Month Change
-11.54%
Year-to-Date (YTD) Change
115.20%
1-Year Change
7.02%
3-Year Change
222.38%
5-Year Change
249.79%
All-Time (Max) Change
512.35%

Contact Information

https://www.corcept.com
650 327 3270
149 Commonwealth Drive, Menlo Park, CA, 94025

Company Facts

500 Employees
IPO DateApr 14, 2004
CountryUS
Actively Trading

Frequently Asked Questions